Henna Salman et al. 2024. SHORT COURSE VS PROLONGED RIFAXIMIN THERAPY FOR POST INFECTIOUS IRRITABLE BOWEL SYNDROME. Journal of Population Therapeutics and Clinical Pharmacology. 31, 3 (Mar. 2024), 145–149. DOI:https://doi.org/10.53555/jptcp.v31i3.4785.